-
News | 2024.12.16
Microbiota tailored skin humoral immunity and its potential for the development of novel vaccinal approaches
Scientists have just made two major discoveries about a harmless bacterium, Staphylococcus epidermidis, present on our skin. A first study identifies the skin as a compartment able to develop highly protective antibody responses to skin colonizing microbe in the absence of inflammation or lymph node contribution. A second study concerns the development of a topical vaccine that can be applied...
-
News | 2025.07.25
Neutralizing human monoclonal antibodies against hepatitis E virus
The Humoral Immunology Unit has identified neutralizing antibodies that are effective against the hepatitis E virus (HEV). They could be used for prevention or treatment against HEV infection, which affects approximately 20 million people worldwide every year. Structural analyses carried out with the NanoImaging Core Facility enabled atomic-scale visualization of the neutralization site...
-
Fiche maladie | 2023.09.15
Legionellosis
Legionellosis is a collective term for diseases caused by Legionella bacteria, including the potentially fatal Legionnaires' disease. The most common species, Legionella pneumophila, causes a severe lung infection. The recent emergence of the disease can be explained by the affinity of Legionella bacteria for modern water supply systems. Although there is no vaccine for Legionnaires' disease, it...
-
Document de presse | 2007.08.31
Rabies - Press kit
September 2007 > Rabies in France in 2007 > Rabies research at the Institut Pasteur > Louis Pasteur and rabies vaccination
-
Fiche pays | 2017.08.21
Poland
Recommended vaccinationsRoutine vaccination:Vaccinations included in the vaccination schedule to be updatedBased on your travel plans:Tick-borne encephalitisIf staying in rural or forest areas between spring and autumn.Children: aged ≥1 yearMalaria preventionThere is no malaria in Poland.(Source: Weekly Epidemiological Bulletin [BEH] – Health Recommendations for Travelers).
-
News | 2023.11.27
The spin-off Oncovita wins the France 2030 call for projects
Oncovita, a spin-off from the Institut Pasteur, has won the call for projects "Innovation in biotherapies and bioproduction" as part of the France 2030 investment plan. The company will receive €4.5 million in funding from Bpifrance to support the development of its immunotherapeutic cancer vaccine, MVdeltaC. The company will also benefit from €3.5 million in private funding. This...
-
News | 2020.04.16
MOOC Vaccinology
NEW EDITION OF THE FREE ON-LINE COURSE OF INSTITUT PASTEUR Realized with the support of the Fondation Ipsen, under the aegis of Fondation de France.Vaccines are among the most effective public health interventions currently available. Several diseases have been eradicated or reduced drastically through vaccination. Together, with antibiotics and clean water, vaccines have increased life...
-
Document de presse | 2008.07.07
Whooping cough: bacterial monitoring for better prevention
Researchers from the Institut Pasteur in Paris and the Institut Pasteur in Lille have analyzed the consequences of intensive vaccination of young children against whooping cough on the bacterium agent of the disease. Their observations highlight the importance of continuing bacterial evolution in order to adapt vaccine strategies. Press release Paris, july 8, 2008 ...
-
Document de presse | 2023.12.14
Working together against deadly Marburg virus
International research consortium receives highly endowed Horizon Europe funding for the development of vaccines against Marburg viruses.The multidisciplinary European consortium MARVAX will receive 7.4 million euros over the next four years for the research and development of vaccines against Marburg viruses. Researchers from France, Spain and Germany will develop novel vaccine candidates, which...
-
News | 2017.10.06
Support for government policy for the prevention of infectious diseases
Scientific, medical, paramedical societies, medical unions and the Institut Pasteur, all signatories below, support the policy for the prevention of infectious diseases implemented by the French Government and the Minister of Health.Vaccines are one of the major achievements of medicine, this is why the companies which sign this text, including the Institut Pasteur, support the French Government'...